McGill University

Running trials

• Not yet recruiting

  A Study of LY3873862 in Participants With Sporadic or Familial Amyotrophic Lateral Sclerosis (ALS).

  NCT07883590· Phase 1· Source

• Not yet recruiting

  Dialysis Less Frequently in the Elderly

  NCT07738731· Source

• Recruiting

  A Phase II Study Evaluating the Efficacy and Safety of Inavolisib Plus Ribociclib Plus Fulvestrant Versus Placebo Plus Ribociclib Plus Fulvestrant in Participants With Advanced Breast Cancer

  NCT07405801· Phase 2· Source

• Recruiting

  Phase 3 Study of Taletrectinib vs Placebo as an Adjuvant Therapy in ROS1 Positive NSCLC (TRUST-IV)

  NCT07154706· Phase 3· Source

• Active, not recruiting

  A Study to Learn More About the Effects and Long-Term Safety of Omaveloxolone (BIIB141) in Children and Teens With Friedreich's Ataxia

  NCT06953583· Phase 3· Source

• Recruiting

  A Study of Lorigerlimab in Participants With Advanced Solid Tumors

  NCT06730347· Phase 2· Source

• Recruiting

  Study of Sacituzumab Govitecan Versus Standard of Care in Participants With Previously Treated Extensive Stage Small Cell Lung Cancer

  NCT06801834· Phase 3· Source

• Enrolling by invitation

  Assessment of Worldwide Acute Kidney Injury Epidemiology in Neonates 2.0

  NCT06823115· Source

• Not yet recruiting

  Pretreatment Botulinum Toxin in Head and Neck Cancer Surgery

  NCT06530524· Phase 2· Source

• Recruiting

  The diabEAT Study: Insulin dElivery Technologies And eaTing Behaviours in People With Type 1 Diabetes

  NCT07348432· Source

• Recruiting

  Fibrosis Lessens After Metabolic Surgery

  NCT06374875· Phase 4· Source

• Active, not recruiting

  MagDI Canada Study

  NCT06467955· Source

• Active, not recruiting

  [Ac-225]-PSMA-62 Trial in Oligometastatic Hormone Sensitive and Metastatic Castration Resistant Prostate Cancer

  NCT06229366· Phase 1· Source

• Recruiting

  Using Micro-filaments to Detect "fast Ripples" and Improve the Identification of the Epileptogenic Zone

  NCT05254730· Source

• Active, not recruiting

  AMP SCZ® Observational Study: PREDICT-DPACC

  NCT05905003· Source

• Active, not recruiting

  Head-to-Head Harmonization of Tau Tracers in Alzheimer's Disease

  NCT05361382· Phase 1· Source

• Recruiting

  Parkinson's Foundation PD GENEration Genetic Registry

  NCT04994015· Source

• Recruiting

  PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort

  NCT04477785· Source

• Active, not recruiting

  SBRT +/- Pembrolizumab in Patients With Local-Regionally Recurrent or Second Primary Head and Neck Carcinoma

  NCT03546582· Phase 2· Source

• Recruiting

  International Severe Asthma Registry: Canadian Cohort

  NCT04045587· Source

• Recruiting

  Quebec Low Back Pain Study: Core Dataset

  NCT04791891· Source

• Enrolling by invitation

  North American Prodromal Synucleinopathy Consortium

  NCT03623672· Source

• Recruiting

  American Hepato-Pancreato-Biliary Association (AHPBA) Pancreatic Irreversible Electroporation (IRE) Registry

  NCT02674100· Source

• Active, not recruiting

  A Study for Cardiovascular and Lifestyle Risk Factors in Prostate Cancer Patients

  NCT03127631· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Chronic kidney disease2 recruiting
• Lung cancer2 recruiting
• Parkinson disease2 recruiting
• ALS (motor neurone disease)1 recruiting
• Asthma1 recruiting
• Endometrial cancer1 recruiting
• Epilepsy1 recruiting
• Fatty liver disease (MASLD/MASH)1 recruiting
• Head and neck cancer1 recruiting
• High blood pressure1 recruiting
• Lewy body dementia1 recruiting
• Metastatic breast cancer1 recruiting
• Obesity1 recruiting
• Ovarian cancer1 recruiting
• Pancreatic cancer1 recruiting
• Type 1 diabetes1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Completed

  Petit Cactus Study

  NCT07380802· Source

• Completed

  Frequency of Selected Single Nucleotide Polymorphisms in Huntington Disease Gene Expansion Carriers

  NCT06667414· Source

• Completed

  A Randomized Trial Evaluating Control-IQ+ Technology in Adults With Type 2 Diabetes

  NCT05785832· Source

• Recruiting

  A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis

  NCT04951622· Phase 3· Source

• Completed

  Development of a Cell Free DNA Assay as a Biomarker for Predicting Early Non-response to Therapy in Metastatic Cancer

  NCT03892096· Source

• Completed

  High Oxygen Delivery to Preserve Exercise Capacity in Idiopathic Pulmonary Fibrosis Patients Treated With Nintedanib

  NCT02551068· Source

• Completed

  A Randomized Controlled Trial of TNK-tPA Versus Standard of Care for Minor Ischemic Stroke With Proven Occlusion

  NCT02398656· Phase 3· Source

• Completed

  LOWER: Lomitapide Observational Worldwide Evaluation Registry

  NCT02135705· Source